Literature DB >> 7998930

Insulin receptor substrate 1 is phosphorylated by the serine kinase activity of phosphatidylinositol 3-kinase.

J F Tanti1, T Grémeaux, E Van Obberghen, Y Le Marchand-Brustel.   

Abstract

Insulin receptor substrate (IRS) 1, which is tyrosine phosphorylated in response to insulin, presents multiple serine/threonine phosphorylation sites. To search for a serine kinase activity towards IRS 1, immunoprecipitates from basal or stimulated 3T3-L1 adipocytes were used in an in vitro kinase assay. When IRS 1 was isolated from insulin-treated cells, serine phosphorylation of IRS 1 occurred, which we attribute to the kinase activity of the phosphatidylinositol 3-kinase (PI3-kinase). Importantly, in an in vitro reconstitution assay, an excess of the PI3-kinase subunit prevents this phosphorylation. Together, our results suggest that following insulin stimulation, PI3-kinase associates with IRS 1, allowing for its serine phosphorylation. This phosphorylation event could play a role in the modulation of insulin signalling.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7998930      PMCID: PMC1137444          DOI: 10.1042/bj3040017

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  32 in total

1.  A tightly associated serine/threonine protein kinase regulates phosphoinositide 3-kinase activity.

Authors:  C L Carpenter; K R Auger; B C Duckworth; W M Hou; B Schaffhausen; L C Cantley
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

2.  Expression and function of IRS-1 in insulin signal transmission.

Authors:  X J Sun; M Miralpeix; M G Myers; E M Glasheen; J M Backer; C R Kahn; M F White
Journal:  J Biol Chem       Date:  1992-11-05       Impact factor: 5.157

3.  Interaction of phosphatidylinositol 3-kinase-associated p85 with epidermal growth factor and platelet-derived growth factor receptors.

Authors:  P Hu; B Margolis; E Y Skolnik; R Lammers; A Ullrich; J Schlessinger
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

4.  Regulation of the expression of pp160, a putative insulin receptor signal protein, by insulin, dexamethasone, and 1-methyl-3-isobutylxanthine in 3T3-L1 adipocytes.

Authors:  K M Rice; G E Lienhard; C W Garner
Journal:  J Biol Chem       Date:  1992-05-15       Impact factor: 5.157

5.  Phosphorylation of the insulin receptor substrate IRS-1 by casein kinase II.

Authors:  M J Tanasijevic; M G Myers; R S Thoma; D L Crimmins; M F White; D B Sacks
Journal:  J Biol Chem       Date:  1993-08-25       Impact factor: 5.157

6.  The insulin and insulin-like growth factor-I receptor substrate IRS-1 associates with and activates phosphatidylinositol 3-kinase in vitro.

Authors:  S Giorgetti; R Ballotti; A Kowalski-Chauvel; S Tartare; E Van Obberghen
Journal:  J Biol Chem       Date:  1993-04-05       Impact factor: 5.157

7.  Insulin stimulates the degradation of IRS-1 in 3T3-L1 adipocytes.

Authors:  K M Rice; M A Turnbow; C W Garner
Journal:  Biochem Biophys Res Commun       Date:  1993-02-15       Impact factor: 3.575

8.  Association of IRS-1 with the insulin receptor and the phosphatidylinositol 3'-kinase. Formation of binary and ternary signaling complexes in intact cells.

Authors:  J M Backer; M G Myers; X J Sun; D J Chin; S E Shoelson; M Miralpeix; M F White
Journal:  J Biol Chem       Date:  1993-04-15       Impact factor: 5.157

9.  Phosphatidylinositol 3'-kinase is activated by association with IRS-1 during insulin stimulation.

Authors:  J M Backer; M G Myers; S E Shoelson; D J Chin; X J Sun; M Miralpeix; P Hu; B Margolis; E Y Skolnik; J Schlessinger
Journal:  EMBO J       Date:  1992-09       Impact factor: 11.598

10.  The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS1 and Shc: implications for insulin control of ras signalling.

Authors:  E Y Skolnik; C H Lee; A Batzer; L M Vicentini; M Zhou; R Daly; M J Myers; J M Backer; A Ullrich; M F White
Journal:  EMBO J       Date:  1993-05       Impact factor: 11.598

View more
  28 in total

1.  Autophosphorylation of p110delta phosphoinositide 3-kinase: a new paradigm for the regulation of lipid kinases in vitro and in vivo.

Authors:  B Vanhaesebroeck; K Higashi; C Raven; M Welham; S Anderson; P Brennan; S G Ward; M D Waterfield
Journal:  EMBO J       Date:  1999-03-01       Impact factor: 11.598

2.  Comparison of the kinetic properties of the lipid- and protein-kinase activities of the p110alpha and p110beta catalytic subunits of class-Ia phosphoinositide 3-kinases.

Authors:  C A Beeton; E M Chance; L C Foukas; P R Shepherd
Journal:  Biochem J       Date:  2000-09-01       Impact factor: 3.857

3.  Turning down insulin signaling.

Authors:  M J Birnbaum
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

4.  IRS1 degradation and increased serine phosphorylation cannot predict the degree of metabolic insulin resistance induced by oxidative stress.

Authors:  R Potashnik; A Bloch-Damti; N Bashan; A Rudich
Journal:  Diabetologia       Date:  2003-05-15       Impact factor: 10.122

5.  Alterations in insulin signalling pathway induced by prolonged insulin treatment of 3T3-L1 adipocytes.

Authors:  J M Ricort; J F Tanti; E Van Obberghen; Y Le Marchand-Brustel
Journal:  Diabetologia       Date:  1995-10       Impact factor: 10.122

6.  Oncogenic transformation induced by the p110beta, -gamma, and -delta isoforms of class I phosphoinositide 3-kinase.

Authors:  Sohye Kang; Adam Denley; Bart Vanhaesebroeck; Peter K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

7.  Molecular mechanism of insulin-induced degradation of insulin receptor substrate 1.

Authors:  Rachel Zhande; John J Mitchell; Jiong Wu; Xiao Jian Sun
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

8.  Fragments of ATM which have dominant-negative or complementing activity.

Authors:  S E Morgan; C Lovly; T K Pandita; Y Shiloh; M B Kastan
Journal:  Mol Cell Biol       Date:  1997-04       Impact factor: 4.272

9.  Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways.

Authors:  L Rui; V Aguirre; J K Kim; G I Shulman; A Lee; A Corbould; A Dunaif; M F White
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

10.  ZAG alleviates HFD-induced insulin resistance accompanied with decreased lipid depot in skeletal muscle in mice.

Authors:  Shi-Xing Gao; Jun Guo; Guo-Qiang Fan; Yu Qiao; Ru-Qian Zhao; Xiao-Jing Yang
Journal:  J Lipid Res       Date:  2018-10-14       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.